Literature DB >> 9374999

Imaging pediatric bone sarcomas. Diagnosis and treatment-related issues.

B D Fletcher1.   

Abstract

The treatment of pediatric bone malignancies has undergone dramatic change in the past two decades. With the use of adjuvant chemotherapy, survival of patients with osteosarcoma and Ewing's sarcoma has greatly increased and most extremity lesions are now managed with an initial course of chemotherapy followed by limb-sparing surgery rather than amputation. Radiologists are called on not only to help diagnose and stage these tumors, but also to assess their extent, to determine response to preoperative chemotherapy, and to monitor patients for postoperative complications and recurrent disease. This article discusses imaging solutions to clinical issues that arise during the care of these children.

Entities:  

Mesh:

Year:  1997        PMID: 9374999

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  6 in total

1.  Usefulness of increased 18F-FDG uptake for detecting local recurrence in patients with extremity osteosarcoma treated with surgical resection and endoprosthetic replacement.

Authors:  Kyoung Jin Chang; Chang-Bae Kong; Wan Hyeong Cho; Dae-Geun Jeon; Soo-Yong Lee; Ilhan Lim; Sang Moo Lim
Journal:  Skeletal Radiol       Date:  2014-11-29       Impact factor: 2.199

2.  Comparison of whole-body STIR-MRI and 99mTc-methylene-diphosphonate scintigraphy in children with suspected multifocal bone lesions.

Authors:  Hans-J Mentzel; K Kentouche; D Sauner; C Fleischmann; S Vogt; D Gottschild; F Zintl; W A Kaiser
Journal:  Eur Radiol       Date:  2004-07-09       Impact factor: 5.315

3.  Whole-body magnetic resonance imaging: a useful additional sequence in paediatric imaging.

Authors:  Eoghan E Laffan; Rachael O'Connor; Stephanie P Ryan; Veronica B Donoghue
Journal:  Pediatr Radiol       Date:  2004-04-24

4.  Prognostic significance of 18F-FDG uptake in primary osteosarcoma after but not before chemotherapy: a possible association with autocrine motility factor/phosphoglucose isomerase expression.

Authors:  Junko Sato; Takashi Yanagawa; Yoh Dobashi; Takehiko Yamaji; Kenji Takagishi; Hideomi Watanabe
Journal:  Clin Exp Metastasis       Date:  2008-02-27       Impact factor: 5.150

5.  Clinical value of ultrasound for the evaluation of local recurrence of primary bone tumors.

Authors:  Yu Wang; Ping Yu; Feifei Liu; Yuqin Wang; Jiaan Zhu
Journal:  Front Oncol       Date:  2022-09-15       Impact factor: 5.738

6.  Evaluation of Response to Therapy in a Patient with Lung Cancer: Correlation of Sclerotic Bone Lesions with F 18 FDG PET/CT and Bone Scintigraphy.

Authors:  Tamer Ozülker; Filiz Ozülker; Aysun Küçüköz Uzun; Tarık Tatoğlu; Tevfik Ozpaçacı
Journal:  Mol Imaging Radionucl Ther       Date:  2011-04-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.